XOMAP earnings: next report 2026-07-30, real EPS beat/miss history, analyst consensus Buy, P/E 24.35. Updated 2026-07-23.
XOMA Royalty (XOMAP) Research Hub
XOMA Royalty (XOMAP) trades on NASDAQ, US in the Healthcare (Medical - Pharmaceuticals) sector. As of 2026-07-20, shares last closed at 24.98 USD (0.00%), in a downtrend — price below falling 50-DMA, 50-DMA below 200-DMA. Valuation: trailing P/E 24.35, market cap 0.30B. This hub links to the full technical, earnings and options research available for XOMAP.
Last updated 2026-07-20 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Pharmaceuticals) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 24.98 USD (0.00%) |
| 52-week range | 24.93 USD – 30 USD |
| Trend regime | Downtrend |
| 14-day RSI | 11.1 (Oversold) |
| Trailing P/E | 24.35 |
| Market cap | 0.30B |
| Dividend yield | 0.00% |
| Next earnings | 2026-07-30 |
Available research for XOMAP
Covered Call on XOMAP: how it works, illustrative setup around the real 24.98 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on XOMAP: how it works, illustrative setup around the real 24.98 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on XOMAP: how it works, illustrative setup around the real 24.98 USD price, max profit/loss, breakeven and when to use it. Educational.
XOMAP technical analysis: downtrend, last 24.98 USD, RSI 11.1, 52w range 24.93 USD–30 USD, real support/resistance. Updated 2026-07-20.
Frequently asked questions
What sector is XOMAP in?
XOMA Royalty (XOMAP) is classified under Healthcare (Medical - Pharmaceuticals), listed on NASDAQ, US.
Is XOMAP in an uptrend or downtrend?
As of 2026-07-20, XOMAP is in a downtrend — price below falling 50-DMA, 50-DMA below 200-DMA. See the full technical research page for support and resistance levels.
What is XOMAP's trailing P/E ratio?
XOMAP's trailing P/E is 24.35, with a market cap of 0.30B. See the earnings research page for full valuation detail.
When does XOMAP next report earnings?
XOMAP is next scheduled to report earnings on 2026-07-30, with a consensus EPS estimate of 0.1761 USD.